Adlai Nortye Group Ltd. income statement

In fiscal 2025, Adlai Nortye Group Ltd. reported revenue of $5.0m, up 0.0% on the year before, operating income of −$35.7m (a -714.0% margin) and net income of −$35.5m, or −$1.11 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Adlai Nortye Group Ltd.: income statement, annual
Fiscal year	2021Dec 2021	2023Dec 2023	2025Dec 2025
Revenue	46	5	5
Research and development	42	58	33
General and administrative	12	15	8
Operating income	−9	−73	−36
Interest expense	0	0	0
Income before tax	−57	−109	−36
Income tax	—	1	—
Net income	−57	−109	−36
Diluted EPS	−$6.69	−$7.56	−$1.11
Diluted shares (average)	8m	14m	32m
EBITDA	—	−72	−35

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ANL vs IVA ANL vs RANI ANL vs IMRN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Adlai Nortye Group Ltd.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adlai Nortye Group Ltd.